Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common type of malignant primary liver tumour, accounting for 80 –90% of all liver cancers. [1] In the USA, for example, 30,640 new liver and intrahepatic bile duct cancers are estimated to have occurred in 2013, with 21,670 associated deaths. [2–3]

Source: Journal of Hepatology - August 13, 2019 Category: Gastroenterology Authors: Jens Ricke, Heinz Josef Klumpen, Holger Amthauer, Irene Bargellini, Peter Bartenstein, Enrico de Toni, Antonio Gasbarrini, Maciej Pech, Markus Peck-Radosavljevic, Peter Popovi č, Olivier Rosmorduc, Eckart Schott, Max Seidensticker, Chris Verslype, Bruno Source Type: research